• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自[具体来源未给出]的苯并菲啶生物碱对BRCA1缺陷癌细胞的合成致死活性。

Synthetic Lethal Activity of Benzophenanthridine Alkaloids From Against BRCA1-Deficient Cancer Cells.

作者信息

García Iris A, Pansa Maria Florencia, Pacciaroni Adriana Del Valle, García Manuela E, Gonzalez Maria Laura, Oberti Juan Carlos, Bocco José Luís, Carpinella Maria Cecilia, Barboza Gloria E, Nicotra Viviana E, Soria Gastón

机构信息

Centro de Investigaciones en Bioquímica Clínica e Inmunología, CIBICI-CONICET, Córdoba, Argentina.

Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.

出版信息

Front Pharmacol. 2020 Dec 3;11:593845. doi: 10.3389/fphar.2020.593845. eCollection 2020.

DOI:10.3389/fphar.2020.593845
PMID:33424604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7793782/
Abstract

Several plants from South America show strong antitumoral properties based on anti-proliferative and/or pro-apoptotic activities. In this work we aimed to identify selective cytotoxic compounds that target BRCA1-deficient cancer cells by Synthetic Lethality (SL) induction. Using a high-throughput screening technology developed in our laboratory, we analyzed a collection of extracts from 46 native plant species from Argentina using a wide dose-response scheme. A highly selective SL-induction capacity was found in an alkaloidal extract from (Fam. Rutaceae). Bio-guided fractionation coupled to HPLC led to the identification of active benzophenanthridine alkaloids. The most potent SL activity was found with the compound oxynitidine, which showed a remarkably low relative abundance in the active fractions. Further validation experiments were performed using the commercially available and closely related analog nitidine, which showed SL-induction activity against various BRCA1-deficient cell lines with different genetic backgrounds, even in the nanomolar range. Exploration of the underlying mechanism of action using BRCA1-KO cells revealed AKT and topoisomerases as the potential targets responsible of nitidine-triggered SL-induction. Taken together, our findings expose an unforeseen therapeutic activity of alkaloids from -spp. that position them as novel lead molecules for drug discovery.

摘要

几种来自南美洲的植物基于抗增殖和/或促凋亡活性表现出强大的抗肿瘤特性。在这项工作中,我们旨在通过合成致死性(SL)诱导来鉴定靶向BRCA1缺陷癌细胞的选择性细胞毒性化合物。使用我们实验室开发的高通量筛选技术,我们采用宽剂量反应方案分析了来自阿根廷的46种本土植物物种的提取物。在一种来自[植物名称](芸香科)的生物碱提取物中发现了高度选择性的SL诱导能力。结合高效液相色谱的生物导向分级分离鉴定出了活性苯并菲啶生物碱。在活性成分中相对丰度极低的氧化苦参啶表现出最强的SL活性。使用市售的密切相关类似物苦参啶进行了进一步的验证实验,该类似物对具有不同遗传背景的各种BRCA1缺陷细胞系均表现出SL诱导活性,甚至在纳摩尔范围内。使用BRCA1基因敲除细胞探索潜在作用机制发现,AKT和拓扑异构酶是苦参啶触发SL诱导的潜在靶点。综上所述,我们的研究结果揭示了[植物名称]物种生物碱具有意想不到的治疗活性,使其成为药物发现的新型先导分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d1d/7793782/c79a81a85f2e/fphar-11-593845-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d1d/7793782/a73220cab39e/fphar-11-593845-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d1d/7793782/841631797e93/fphar-11-593845-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d1d/7793782/8fd4ffe0c12b/fphar-11-593845-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d1d/7793782/c79a81a85f2e/fphar-11-593845-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d1d/7793782/a73220cab39e/fphar-11-593845-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d1d/7793782/841631797e93/fphar-11-593845-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d1d/7793782/8fd4ffe0c12b/fphar-11-593845-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d1d/7793782/c79a81a85f2e/fphar-11-593845-g004.jpg

相似文献

1
Synthetic Lethal Activity of Benzophenanthridine Alkaloids From Against BRCA1-Deficient Cancer Cells.来自[具体来源未给出]的苯并菲啶生物碱对BRCA1缺陷癌细胞的合成致死活性。
Front Pharmacol. 2020 Dec 3;11:593845. doi: 10.3389/fphar.2020.593845. eCollection 2020.
2
Validation of use of a traditional antimalarial remedy from French Guiana, Zanthoxylum rhoifolium Lam.法属圭亚那传统抗疟药物刺花椒(Zanthoxylum rhoifolium Lam.)使用的验证
J Ethnopharmacol. 2006 Jul 19;106(3):348-52. doi: 10.1016/j.jep.2006.01.011. Epub 2006 Feb 28.
3
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.通过诱导合成致死作用,抑制Polo样激酶1作为一种治疗方法,用于选择性靶向BRCA1缺陷的癌细胞。
Clin Cancer Res. 2019 Jul 1;25(13):4049-4062. doi: 10.1158/1078-0432.CCR-18-3516. Epub 2019 Mar 19.
4
Structure-activity relationship of benzophenanthridine alkaloids from Zanthoxylum rhoifolium having antimicrobial activity.具有抗菌活性的芸香科植物刺花椒中苯并菲啶生物碱的构效关系。
PLoS One. 2014 May 13;9(5):e97000. doi: 10.1371/journal.pone.0097000. eCollection 2014.
5
Comparative study on alkaloids and their anti-proliferative activities from three Zanthoxylum species.三种花椒属植物生物碱及其抗增殖活性的比较研究
BMC Complement Altern Med. 2017 Sep 12;17(1):460. doi: 10.1186/s12906-017-1966-y.
6
Cytotoxic Benzophenanthridine and Furoquinoline Alkaloids from Zanthoxylum buesgenii (Rutaceae).来自竹叶椒(芸香科)的细胞毒性苯并菲啶和呋喃喹啉生物碱。
Chem Cent J. 2014 Oct 21;8(1):61. doi: 10.1186/s13065-014-0061-4. eCollection 2014.
7
Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ aggregation.花椒根中的异喹啉生物碱作为乙酰胆碱酯酶、单胺氧化酶 A 和 Aβ聚集的多靶点抑制剂。
Bioorg Chem. 2020 May;98:103722. doi: 10.1016/j.bioorg.2020.103722. Epub 2020 Mar 4.
8
Cytotoxicity of benzophenanthridine alkaloids from the roots of Zanthoxylum nitidum (Roxb.) DC. var. fastuosum How ex Huang.两面针(Zanthoxylum nitidum (Roxb.) DC. var. fastuosum How ex Huang.)根中苯并菲啶生物碱的细胞毒性
Nat Prod Res. 2015;29(14):1380-3. doi: 10.1080/14786419.2014.1002090. Epub 2015 Feb 3.
9
Metabolomic profiling of Zanthoxylum species: Identification of anti-cholinesterase alkaloids candidates.黄檗属植物代谢组学分析:鉴定抗胆碱酯酶生物碱候选物。
Phytochemistry. 2019 Dec;168:112128. doi: 10.1016/j.phytochem.2019.112128. Epub 2019 Sep 23.
10
Apoptosis inducing activity of benzophenanthridine-type alkaloids and 2-arylbenzofuran neolignans in HCT116 colon carcinoma cells.苯并菲啶型生物碱和 2-芳基苯并呋喃新木脂素在 HCT116 结肠癌细胞中的凋亡诱导活性。
Phytomedicine. 2013 Jul 15;20(10):923-9. doi: 10.1016/j.phymed.2013.03.026. Epub 2013 Apr 30.

引用本文的文献

1
Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells.Rho 激酶(ROCK)抑制剂在 BRCA2 缺陷细胞中诱导多种有丝分裂缺陷和合成致死。
Elife. 2023 Apr 19;12:e80254. doi: 10.7554/eLife.80254.
2
Natural products targeting cancer cell dependency.针对癌细胞依赖性的天然产物。
J Antibiot (Tokyo). 2021 Oct;74(10):677-686. doi: 10.1038/s41429-021-00438-x. Epub 2021 Jun 23.

本文引用的文献

1
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.天然产物:1981 年 1 月至 2019 年 9 月近四十年来的新药来源
J Nat Prod. 2020 Mar 27;83(3):770-803. doi: 10.1021/acs.jnatprod.9b01285. Epub 2020 Mar 12.
2
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.BRCAness、SLFN11和RB1缺失可预测三阴性乳腺癌对拓扑异构酶I抑制剂的反应。
Sci Transl Med. 2020 Feb 19;12(531). doi: 10.1126/scitranslmed.aax2625.
3
Antitumor functions and mechanisms of nitidine chloride in human cancers.
氯化两面针碱在人类癌症中的抗肿瘤作用及机制
J Cancer. 2020 Jan 1;11(5):1250-1256. doi: 10.7150/jca.37890. eCollection 2020.
4
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.尼拉帕利治疗新诊断的晚期卵巢癌患者。
N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28.
5
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells.聚腺苷二磷酸核糖聚合酶抑制剂耐药性:BRCA 突变细胞中的拔河比赛。
Trends Cell Biol. 2019 Oct;29(10):820-834. doi: 10.1016/j.tcb.2019.07.008. Epub 2019 Aug 14.
6
Overview: FDA Approval of Olaparib Maintenance for BRCA-Mutated.概述:奥拉帕利用于BRCA突变维持治疗获美国食品药品监督管理局批准。
Oncology (Williston Park). 2019 Jul 15;33(7):629388.
7
Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology.基于结构系统药理学的理性发现双重适应证多靶标 PDE/激酶抑制剂用于精准抗癌治疗。
PLoS Comput Biol. 2019 Jun 17;15(6):e1006619. doi: 10.1371/journal.pcbi.1006619. eCollection 2019 Jun.
8
Maintenance Olaparib for Germline -Mutated Metastatic Pancreatic Cancer.维持奥拉帕利治疗种系突变转移性胰腺癌。
N Engl J Med. 2019 Jul 25;381(4):317-327. doi: 10.1056/NEJMoa1903387. Epub 2019 Jun 2.
9
Natural products: An upcoming therapeutic approach to cancer.天然产物:癌症治疗的新兴方法。
Food Chem Toxicol. 2019 Jun;128:240-255. doi: 10.1016/j.fct.2019.04.012. Epub 2019 Apr 13.
10
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.通过诱导合成致死作用,抑制Polo样激酶1作为一种治疗方法,用于选择性靶向BRCA1缺陷的癌细胞。
Clin Cancer Res. 2019 Jul 1;25(13):4049-4062. doi: 10.1158/1078-0432.CCR-18-3516. Epub 2019 Mar 19.